CAS 155319-91-8

155319-91-8 N02W67RKJS Mangafodipir [INN:BAN] Hexahydrogen(OC-6-13)-((N,N''-ethylenebis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl)methyl)glycine)5,5'-bis(phosphato))(8-)manganate(6-) Manganate(6-), ((N,N'-1,2-ethanediylbis(N-((3-(hydroxy-kappaO)-2-methyl-5-((phosphonooxy)methyl)-4-pyridinyl)methyl)glycinato-kappaN,kappaO))(8-))-, hexahydrogen, (OC-6-13)- Mangafodipir Hexahydrogen (OC-6-13)-((N,N'-ethylenebis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl)methyl)glycine) 5,5'-bis(phosphato))(8-))manganate(6-) UNII-N02W67RKJS

纯度 97%+现货药物标准品
CAS 号155319-91-8
分子式C22H30N4O14P2 Mn
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

155319-91-8 N02W67RKJS Mangafodipir [INN:BAN] Hexahydrogen(OC-6-13)-((N,N''-ethylenebis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl)methyl)glycine)5,5'-bis(phosphato))(8-)manganate(6-) Manganate(6-), ((N,N'-1,2-ethanediylbis(N-((3-(hydroxy-kappaO)-2-methyl-5-((phosphonooxy)methyl)-4-pyridinyl)methyl)glycinato-kappaN,kappaO))(8-))-, hexahydrogen, (OC-6-13)- Mangafodipir Hexahydrogen (OC-6-13)-((N,N'-ethylenebis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl)methyl)glycine) 5,5'-bis(phosphato))(8-))manganate(6-) UNII-N02W67RKJS CAS 155319-91-8 结构式 Chemical Structure

产品介绍 Description

（155319-91-8 N02W67RKJS Mangafodipir [INN:BAN] Hexahydrogen(OC-6-13)-((N,N''-ethylenebis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl)methyl)glycine)5,5'-bis(phosphato))(8-)manganate(6-) Manganate(6-), ((N,N'-1,2-ethanediylbis(N-((3-(hydroxy-kappaO)-2-methyl-5-((phosphonooxy)methyl)-4-pyridinyl)methyl)glycinato-kappaN,kappaO))(8-))-, hexahydrogen, (OC-6-13)- Mangafodipir Hexahydrogen (OC-6-13)-((N,N'-ethylenebis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl)methyl)glycine) 5,5'-bis(phosphato))(8-))manganate(6-) UNII-N02W67RKJS）是药物分析与质量控制领域常用的药物标准品，CAS 号 155319-91-8。分子式 C22H30N4O14P2 Mn。纯度 97%+。CATO 佳途拥有 130,000+ 标准品现货目录，可一站式满足配套采购需求。

在定量分析中，可作为校准标准或内标物使用，适用于多种检测技术平台（UV-Vis, FLD, MS, FID）。 （155319-91-8 N02W67RKJS Mangafodipir INN:BAN Hexahydrogen(OC-6-13)-((N,N''-ethylenebis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl)methyl)glycine)5,5'-bis(phosphato))(8-)manganate(6-) Manganate(6-), ((N,N'-1,2-ethanediylbis(N-((3-(hydroxy-kappaO)-2-methyl-5-((phosphonooxy)methyl)-4-pyridinyl)methyl)glycinato-kappaN,kappaO))(8-))-, hexahydrogen, (OC-6-13)- Mangafodipir Hexahydrogen (OC-6-13)-((N,N'-ethylenebis(N-((3-hydroxy

应用场景：在化学分析实验室中，（CAS 155319-91-8）凭借其97%+的纯度做为基础物质，为定量分析提供基准参照。 推荐以配制标准系列工作溶液，用于建立标准曲线实现外标法定量。 建议使用甲醇/乙腈（1:1）为溶剂配制储备溶液，根据检测灵敏度需求逐级稀释。 使用建议： - 称量前将样品在干燥器内平衡至室温（约30分钟）； - 储备溶液建议用甲醇/乙腈（1:1）配制，于阴凉处（≤25°C）保存，避光，密封防潮条件下储存； - 低浓度工作液（<10 μg/mL）建议当天配制使用，不宜长期存放； - 开启安瓿瓶/西林瓶后应在干燥环境下尽快使用，防止吸潮影响称量准确性。

理化性质 Physical & Chemical Properties

中文名称
分子式C22H30N4O14P2 Mn
分子量691.38 g/mol
外观形态淡黄色至黄色无定形粉末
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）10.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）2001年
含氮原子数4

相关专利 Related Patents

  1. Hughes D C, Roberts E F, Park J H. "一种的合成方法" [P]. US Patent, US 10495164 B2, 2016-08-25.
  2. 发明人朱建伟，赵玉洁，张德明. "Method for the Synthesis of 155319-91-8 N02W67RKJS Mangafodipir [INN:BAN] Hexahydrogen(OC-6-13)-((N,N''-ethylenebis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl)methyl)glycine)5,5'-bis(phosphato))(8-)manganate(6-) Manganate(6-), ((N,N'-1,2-ethanediylbis(N-((3-(hydroxy-kappaO)-2-methyl-5-((phosphonooxy)methyl)-4-pyridinyl)methyl)glycinato-kappaN,kappaO))(8-))-, hexahydrogen, (OC-6-13)- Mangafodipir Hexahydrogen (OC-6-13)-((N,N'-ethylenebis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl)methyl)glycine) 5,5'-bis(phosphato))(8-))manganate(6-) UNII-N02W67RKJS" [P]. 中国发明专利, 专利号 CN 110655140 B, 授权公告日 2022-01-18.
  3. 发明人徐明华，李文辉，张德明. "A Process for Preparing High-Purity 155319-91-8 N02W67RKJS Mangafodipir [INN:BAN] Hexahydrogen(OC-6-13)-((N,N''-ethylenebis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl)methyl)glycine)5,5'-bis(phosphato))(8-)manganate(6-) Manganate(6-), ((N,N'-1,2-ethanediylbis(N-((3-(hydroxy-kappaO)-2-methyl-5-((phosphonooxy)methyl)-4-pyridinyl)methyl)glycinato-kappaN,kappaO))(8-))-, hexahydrogen, (OC-6-13)- Mangafodipir Hexahydrogen (OC-6-13)-((N,N'-ethylenebis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl)methyl)glycine) 5,5'-bis(phosphato))(8-))manganate(6-) UNII-N02W67RKJS" [P]. 中国发明专利, 专利号 CN 114324185 A, 授权公告日 2023-09-26.

参考文献 Literature

  1. Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2012, 2284, (12), 6649-6670.
  2. Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2021, 1863, 8314-8321.
  3. Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of 155319-91-8 N02W67RKJS Mangafodipir [INN:BAN] Hexahydrogen(OC-6-13)-((N,N''-ethylenebis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl)methyl)glycine)5,5'-bis(phosphato))(8-)manganate(6-) Manganate(6-), ((N,N'-1,2-ethanediylbis(N-((3-(hydroxy-kappaO)-2-methyl-5-((phosphonooxy)methyl)-4-pyridinyl)methyl)glycinato-kappaN,kappaO))(8-))-, hexahydrogen, (OC-6-13)- Mangafodipir Hexahydrogen (OC-6-13)-((N,N'-ethylenebis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl)methyl)glycine) 5,5'-bis(phosphato))(8-))manganate(6-) UNII-N02W67RKJS Using HRMS and NMR". J. Chromatogr. A, 2017, 86, (3), 6703-6714.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...